Skip to content

Operating Income at other companies

AbbVie logo
AbbVieABBV
$3.99B+6.9%
Establishment Labs logo
Establishment LabsESTA
-$6.51M+61.6%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$950M-444%

Segments

By segment

See full
Reportable Segment-$1.8M-13.4%

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total debt$71.0M-27.1%
Total equity$100.3M+31.5%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$311.81M+4.7%
Enterprise value$366.14M-6.0%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
Net margin-11.3%-25.1pp
FCF margin-0.1%

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.6×
Current ratio0.7×+0.2×

Where this comes from

Reported directly by AirSculpt Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s operating income?
AirSculpt Technologies, Inc. (AIRS) reported operating income of -$1.8M in Q1 2026.
How has AirSculpt Technologies, Inc.'s operating income changed year-over-year?
AirSculpt Technologies, Inc.'s operating income decreased by 13.4% year-over-year, from -$1.59M to -$1.8M.
What is the long-term trend for AirSculpt Technologies, Inc.'s operating income?
Over 3 years (2022 to 2025), AirSculpt Technologies, Inc.'s operating income has grown at a 36.5% compound annual growth rate (CAGR), from -$4.55M to -$11.56M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.